New students: get 15% off your first order with code WELCOME15 Claim offer

admin 1 min read Nursing

[Expert Solution]: Which of the following is accurate…

Need help with your Endocrine & Metabolic Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.

Which of the following is accurate regarding semaglutide’s new indication to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD)? A. The American Diabetes Association guidelines purposefully do not recognize this data B. This indication is based on clinical study data versus metformin C. This indication is specific to patients with significantly uncontrolled diabetes D. Semaglutide is the first GLP-1 agonist to have received this indication

Share:
Was this helpful?

Take the next step with this assignment

Every order includes a free originality report, unlimited revisions and 24/7 human support.

  • Subject expert matched to your exact course
  • Original work, written from scratch for you
  • On-time delivery, with free revisions
Purchase This Solution Order a Custom Written Paper

Secure checkout · Confidential service · No reselling